PCSK9 inhibition: ready for prime time in CKD? by Mafham, M, Haynes, R

What is the association of COVID-19 with heart attacks and strokes? by Mafham, M, Baigent, C

HARMONY or discord in cardiovascular outcome trials of GLP-1 receptor agonists? by Mafham, M, Preiss, D

PCSK9 inhibition: the dawn of a new age in cholesterol lowering? by Preiss, D, Mafham, M

Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysis. by Mafham, M, Emberson, J, Landray, M, Wen, C, Baigent, C

Towards an understanding of the ethics of electronic consent in clinical trials by Sahan, K, Wijesurendra, R, Preiss, D, Mafham, M, Sheehan, M

Performance of the UKPDS Outcomes Model 2 in a contemporary UK type 2 diabetes trial cohort by Keng, MJ, Leal, J, Mafham, M, Bowman, L, Armitage, J, Mihaylova, B

Vitamin D and calcium for the prevention of fracture: A systematic review and meta-analysis by Yao, P, Bennett, D, Mafham, M, Armitage, J, Chen, Z, Clarke, R

Cystatin C and risk of vascular and nonvascular mortality: a prospective cohort study of older men. by Emberson, JR, Haynes, R, Dasgupta, T, Mafham, M, Landray, M, Baigent, C, Clarke, R

A practical method of measuring glomerular filtration rate by iohexol clearance using dried capillary blood spots. by Mafham, M, Niculescu-Duvaz, I, Barron, J, Emberson, JR, Dockrell, M, Landray, M, Baigent, C

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial by Parish, S, Buck, G, Aung, T, Mafham, M, Clark, S, Hill, M, Collins, R, Bowman, L, Armitage, J

Making trials part of good clinical care: lessons from the RECOVERY trial by Pessoa-Amorim, G, Campbell, M, Fletcher, L, Horby, P, Landray, M, Mafham, M, Haynes, R

A biomarker-based biological age in UK Biobank: composition and prediction of mortality and hospital admissions by Chan, MS, Arnold, M, Offer, A, Hammami, I, Mafham, M, Armitage, J, Perera, R, Parish, S

Data provenance and integrity of health-care systems data for clinical trials by Murray, ML, Love, SB, Carpenter, JR, Hartley, S, Landray, MJ, Mafham, M, Parmar, MKB, Pinches, H, Sydes, MR

ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes by Bowman, L, Mafham, M, Stevens, W, Haynes, R, Buck, G, Collins, R, Armitage, J, ASCEND Study Collaborative Group

Methylprednisolone, intravenous immunoglobulin, tocilizimab or anakinra for children with Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS CoV-2 (PIMS-T... by Haynes, R, Landray, M, Staplin, N, Spata, E, Peto, L, Knight, M, Mafham, M, Emberson, J, Horby, P

Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial by Rocca, B, Buck, G, Petrucci, G, Parish, S, Pagliaccia, F, Baigent, C, Mafham, M, Bowman, L, Armitage, J, Patrono, C

Role of primary and secondary care data in atrial fibrillation ascertainment: impact on risk factor associations, patient management, and mortality in UK Biobank by Camm, CF, Von Ende, A, Gajendragadkar, PR, Pessoa-Amorim, G, Mafham, M, Allen, N, Parish, S, Casadei, B, Hopewell, JC

Dexamethasone in hospitalized patients with Covid-19 — preliminary report by Horby, P, Lim, WS, Emberson, J, Mafham, M, Bell, JL, Linsell, L, Staplin, N, Juszczak, E, Haynes, R, Landray, M

Effects of omega−3 fatty acid supplements on arrhythmias by Parish, S, Mafham, M, Offer, A, Barton, J, Wallendszus, K, Stevens, W, Buck, G, Haynes, R, Collins, R, Bowman, L, Armitage, J